
CNS Pharmaceuticals, Inc.
CNSPHealthcare|Biotechnology|US
$3.92
-0.09 (-2.24%)
DCF Value
$7.67
Tangible Book / Share
$2.66
Cash / Share
$2.92
Next Earnings Report
Nov 18, 2026
EPS est. -$0.27
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest May 26, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Awaiting Results (1)
Trials past primary completion date but still active — data readout may be imminent.
Recent Press Releases
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
Sep 1, 2026 · Accesswire
CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference
Aug 27, 2026 · Accesswire
SEC Filings (56)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 2, 2026 | 8-K | Material event | DocumentIndex |
| Aug 25, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Aug 21, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 2, 2026 | 8-K | Material event | DocumentIndex |
| May 26, 2026 | EFFECT | DocumentIndex | |
| May 26, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| May 19, 2026 | D | DocumentIndex | |
| May 19, 2026 | S-3 | Shelf registration | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 4, 2026 | 8-K | Material event | DocumentIndex |
| Apr 30, 2026 | 10-K/A | Annual report | DocumentIndex |
| Apr 17, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Mar 31, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 11, 2026 | 8-K | Material event | DocumentIndex |
| Mar 2, 2026 | 8-K | Material event | DocumentIndex |
| Feb 27, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Feb 17, 2026 | 8-K | Material event | DocumentIndex |
| Feb 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Dec 17, 2025 | 8-K | Material event | DocumentIndex |
| Nov 21, 2025 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 12, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Nov 4, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Oct 28, 2025 | ARS | Annual report to holders | DocumentIndex |
| Oct 24, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 10, 2025 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Sep 19, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Aug 14, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Jul 22, 2025 | 8-K | Material event | DocumentIndex |
| Jul 15, 2025 | 8-K | Material event | DocumentIndex |
| May 15, 2025 | 10-Q | Quarterly report | DocumentIndex |
| May 15, 2025 | 8-K | Material event | DocumentIndex |
| May 14, 2025 | 424B4 | Offering prospectus | DocumentIndex |
| May 13, 2025 | EFFECT | DocumentIndex | |
| May 12, 2025 | S-1/A | IPO / offering registration | DocumentIndex |